A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Sulfacytine
Tiratricol
Tiratricol may decrease the hypoglycemic activities of Canagliflozin.
Sulfacytine
Ubrogepant
The serum concentration of Ubrogepant can be increased when it is combined with Canagliflozin.
Sulfacytine
Cenobamate
The serum concentration of Canagliflozin can be decreased when it is combined with Cenobamate.
Sulfacytine
Prednisolone acetate
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Canagliflozin.
Sulfacytine
Betamethasone phosphate
The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Canagliflozin.
Sulfacytine
Melengestrol acetate
The risk or severity of hyperglycemia can be increased when Melengestrol acetate is combined with Canagliflozin.
Sulfacytine
Clocortolone acetate
The risk or severity of hyperglycemia can be increased when Clocortolone acetate is combined with Canagliflozin.
Sulfacytine
Prednisone acetate
The risk or severity of hyperglycemia can be increased when Prednisone acetate is combined with Canagliflozin.
Sulfacytine
Methylprednisolone hemisuccinate
The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Canagliflozin.
Sulfacytine
Methylprednisolone aceponate
The risk or severity of hyperglycemia can be increased when Methylprednisolone aceponate is combined with Canagliflozin.
Sulfacytine
Fluprednidene acetate
The risk or severity of hyperglycemia can be increased when Fluprednidene acetate is combined with Canagliflozin.
Sulfacytine
Prednisolone hemisuccinate
The risk or severity of hyperglycemia can be increased when Prednisolone hemisuccinate is combined with Canagliflozin.
Sulfacytine
Prednisolone phosphate
The risk or severity of hyperglycemia can be increased when Prednisolone phosphate is combined with Canagliflozin.
Sulfacytine
Loteprednol
The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Canagliflozin.
Sulfacytine
Hydrocortisone succinate
The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Canagliflozin.
Sulfacytine
Hydrocortisone valerate
The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Canagliflozin.
Sulfacytine
Hydrocortisone probutate
The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Canagliflozin.
Sulfacytine
Hydrocortisone cypionate
The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Canagliflozin.
Sulfacytine
Hydrocortisone butyrate
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Canagliflozin.
Sulfacytine
Hydrocortisone acetate
The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Canagliflozin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3